Dr Michalis Papadakis is the CEO and co-founder of Brainomix. He leads the management team, commercial strategy, fund raising, and corporate partnerships. He has grown the company from the ground up, building the company’s global presence and has raised more than £30 million of private investment and public funding. When he founded Brainomix he was the Scientific Director of the preclinical stroke lab at the University of Oxford. He has a BSc Honours in Biochemistry from Imperial College London and a PhD in neurosciences from UCL School of Pharmacy. He has been an invited speaker at international scientific and innovation conferences.

Eric is the CTO of Brainomix. He received his 1st class M.Eng.in Engineering from Cambridge University, and has worked on a wide variety of computer vision projects. These include video processing and 3D graphics algorithms, real-time data capture software, parallel grid computing systems, and data visualization. He has extensive experience in software engineering, design, and programming with languages such as C++ and Python. At Brainomix, Eric works with the clinical and business teams to deliver the company's state-of-the-art medical imaging software.

Dr George Harston is Chief Medical and Innovation Officer at Brainomix. He is also a Consultant Physician in Stroke and General Medicine at Oxford University Hospitals NHS Foundation Trust. George is responsible for leading translational research, managing clinical and academic collaborations, and leading innovation at Brainomix. George received his medical degree from the University of Cambridge in 2006. In 2015 George was awarded a DPhil (PhD) from the University of Oxford, following which he continued his research and clinical activity as Clinical Lecturer in Oxford. His academic interests centre around the use of imaging biomarkers to optimise the translation of treatments into clinical practice to improve patient care.

Jeff is Chief Marketing & Business Development Officer for Brainomix. He received a BA in Modern History from Brown University in Rhode Island, USA, and also studied at Oxford University as a Visiting Scholar. Jeff is responsible for Brainomix’s marketing function, launching key strategic initiatives, and identifying and driving business development opportunities across all channels. Prior to joining Brainomix in early 2019, he worked at Medtronic for 14 years serving in European and Global Marketing roles.

Gwilym is the Head of Quality Assurance and Regulatory Affairs for Brainomix. He has a BScEcon Honours degree in International Politics and a Master’s degree in International Relations from Aberystwyth University. He is responsible for regulatory compliance and quality management and leads international regulatory clearance activities. Gwilym has 15 years of extensive experience in quality assurance and regulatory affairs for medical imaging software devices and has worked for large multinational companies as well as start-ups and SMEs.

Riaz is Vice President Healthcare Global at Brainomix. He has a BSc Honours degree in Human Genetics from King’s College London and a Masters degree in Human Molecular Genetics from Imperial College London. He is responsible for the company’s revenue, direct sales operations and the management of distributor, agent and channel strategies globally. He leads the development of national and international sales strategies and manages relationships with clinicians and key opinion leaders in each country after market entry. He has held a number of senior management and commercial positions in Pharmaceuticals, Management Information, Health Consultancy and Technology with over 17 years’ experience of working with private and public healthcare.